You are required to be logged in to access the full website
User Name: Password:
Click here if you have forgotten your username or password
  • Home
  • Latest News
  • Search
  • About M2 Pharma
  • Subscribe
Business & Finance
Generics
Therapy Areas
Policy & Regulation
Research & Development
People
Therapy Areas: Oncology
Aro Biotherapeutics Names Cancer Biologist McMahon and Protein Structure and Design Expert Swanson to its Scientific Advisory Board
Login
Username:

Password:


Related Headlines

PharmaEssentia secures Health Canada approval for BESREMi in polycythaemia vera

Anixa Biosciences advances ovarian cancer CAR-T trial to highest dose level

Signatera study links MRD status to survival benefit from chemotherapy in colorectal liver metastases

Northwest Biotherapeutics presents on propensity score matching at BNOS 2026

Taiwan biomedical startups hold over 100 business meetings at BIO 2026

Sanyou Bio and Baiyunshan Xihe partner to develop radiopharmaceuticals and radiodiagnostics

Novartis to acquire Myricx Bio in deal worth up to USD1.5bn

Data from Partner Therapeutics' eNRGy trial of zenocutuzumab published in Journal of Clinical Oncology

Genentech reports positive Phase III results for divarasib in KRAS G12C lung cancer

Alligator Bioscience reports first patient dosed in early-stage breast cancer study

Abbisko Therapeutics and AstraZeneca collaborate to conduct combination clinical trial for NSCLC

Caris Life Sciences introduces Caris Detect multi-cancer early detection blood test

Cumberland Pharmaceuticals sharpens focus on rare disease pipeline with USD100m sale of branded US business to Apotex

SciBase submits FDA filing to expand Nevisense use to non‑melanoma skin cancers

Biovica secures Japanese patent for immuno-oncology TKa application

Home | Business & Finance | Generics | Therapy Areas | Policy & Regulation | Research & Development | People | Search | About M2 Pharma | Subscribe
Copyright © 2026